Valo Health To Participate in Piper Sandler's 34th Annual Healthcare Conference

Error message

Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

BOSTON, Nov. 16, 2022 /PRNewswire/ -- Valo Health, Inc ("Valo") , the technology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence, today announced that its founder & CEO, David Berry, will present at Piper Sandler's 34th Annual Healthcare Conference at The Lotte New York Palace, New York, NY, on Thursday, December 1, 2022 at 8:10 AM (Kennedy 1, 4th Floor).

Metadata

Provider:

PR Newswire

Retrieved on:

Wednesday, November 16, 2022

Information

Tags:

Valo, Conference, Technology, Kennedy, Health, Founder CEO, Time, 4th floor, Piper Sandler Companies, Neurodegeneration, Flagship Pioneering, Artificial intelligence, CEO, Drug discovery, CA, Lotte New York Palace Hotel, Drug development, Architecture, Pharmaceutical industry

Geotags:

NEW YORK, MASSACHUSETTS, SAN FRANCISCO, MA, NY, BOSTON, CT

⚠ partially generated by AI ↴

Organisation:

VALO HEALTH, VALO HEALTH LLC, PIPER SANDLER 34TH ANNUAL HEALTHCARE CONFERENCE

Summary

Key Points:

BOSTON, Nov. 16, 2022 /PRNewswire/ -- Valo Health, Inc ("Valo") , the technology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence, today announced that its founder & CEO, David Berry, will present at Piper Sandler's 34th Annual Healthcare Conference at The Lotte New York Palace, New York, NY, on Thursday, December 1, 2022 at 8:10 AM (Kennedy 1, 4th Floor).
Valo Health, Inc ("Valo") is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence driven computation.
As a digitally native company, Valo aims to fully integrate human-centric data across the entire drug development life cycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates.
Founded by Flagship Pioneering and headquartered in Boston, MA, Valo also has offices in Lexington, MA, New York, NY, Branford, CT, and San Francisco, CA.

Valo Health To Participate in Piper Sandler's 34th Annual Healthcare Conference

BOSTON, Nov. 16, 2022 /PRNewswire/ -- Valo Health, Inc ("Valo"), the technology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence, today announced that its founder & CEO, David Berry, will present at Piper Sandler's 34th Annual Healthcare Conference at The Lotte New York Palace, New York, NY, on Thursday, December 1, 2022 at 8:10 AM (Kennedy 1, 4th Floor).

About Valo Health

Valo Health, Inc ("Valo") is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence driven computation. As a digitally native company, Valo aims to fully integrate human-centric data across the entire drug development life cycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates. The company's Opal Computational Platform^™ is an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative disease. Founded by Flagship Pioneering and headquartered in Boston, MA, Valo also has offices in Lexington, MA, New York, NY, Branford, CT, and San Francisco, CA. To learn more, visit www.valohealth.com.

Contacts:
Investors: Graeme Bell, Chief Financial Officer
[email protected]

Media: Jennifer Hanley, VP Corporate Communications
[email protected]

View original content:https://www.prnewswire.com/news-releases/valo-health-to-participate-in-piper-sandlers-34th-annual-healthcare-conference-301680766.html

SOURCE Valo Health LLC